Announcement

Collapse
No announcement yet.

Seasonal Flu 2008 - 2009

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • Seasonal Flu 2008 - 2009

    Sanofi Pasteur Shipping First Doses of Influenza Vaccine for the 2008-2009 Season in the US

    Posted on: Friday, 1 August 2008, 12:01 CDT
    SWIFTWATER, Pa. and LYON, France, Aug. 1 /PRNewswire/ -- Sanofi Pasteur, the vaccines division of sanofi-aventis Group, began shipping influenza vaccine (Fluzone(R), Influenza Virus Vaccine) in the United States for the 2008-2009 season. The first 1.3 million doses of influenza vaccine began shipping this week following marketing clearance of the 2008-2009 formulation by the U.S. Food and Drug Administration (FDA) on July 14, 2008.
    Vaccine shipments to health-care providers and to the Centers for Disease Control and Prevention (CDC) for distribution through the Vaccines for Children Program will continue through the fall and are planned to be completed in October.
    This year's influenza vaccine contains three new strains of the influenza virus, A/Brisbane/59/2007 (H1N1)-like virus; A/Brisbane/10/2007 (H3N2)-like virus; B/Florida/4/2006-like virus. The three strains for the new influenza vaccine formulation were confirmed by the FDA's Vaccines and Related Biological Products Advisory Committee in February 2008 and correspond with recommendations made by the World Health Organization in February. Unlike other routinely recommended vaccines whose formulation remains constant over time, influenza vaccine is formulated each year to match the strains predicted to circulate during the upcoming season.
    "Introduction of three new strains for the influenza vaccine was unprecedented and could have resulted in a low yield or delay given our tight production timeline. Despite these challenges, we are pleased that once again sanofi pasteur has demonstrated its reliability in supplying Fluzone vaccine to the U.S. market," said Wayne Pisano, President and Chief Executive Officer, sanofi pasteur. "The early shipment of Fluzone vaccine by sanofi pasteur gives health-care providers greater flexibility in planning their vaccination efforts."
    As the world's leading influenza vaccine manufacturer, sanofi pasteur produces approximately half of the influenza vaccine distributed worldwide and in the U.S. produced more than 40 percent of the influenza vaccine distributed for the 2007-2008 influenza season. Sanofi Pasteur is committed to raising immunization rates and improving global access to vaccines. As part of this commitment, the company is expanding its influenza vaccine production facility in the United States. This expansion, slated to come on-line to produce vaccine for the 2009-2010 season, will more than double sanofi pasteur's U.S. production capacity.
    "As a manufacturer, one of our primary objectives is to be responsive to the requests of our customers for early influenza vaccine shipments. In planning their vaccination efforts, it is important for health-care providers and the public to realize that while influenza immunization programs often occur in the early fall, the influenza season itself does not typically peak until February, with disease appearing as late as May. This allows many months for providers to administer influenza vaccine to their patients," said Pisano.


    Influenza Immunization Recommendations
    The CDC recommends that health-care providers begin offering influenza vaccine as soon as vaccine becomes available, and continue immunization efforts throughout the season. Health-care providers are urged to continue immunization efforts until the end of influenza season. Approximately 250 million people, or 4 out of 5 residents of the U.S., are recommended to receive the influenza vaccine annually. The CDC recommends an annual influenza immunization for anyone who wishes to reduce their risk of contracting influenza; children 6 months through 18 years of age; adults over 50 years of age; pregnant women; and anyone with chronic health conditions, such as asthma, chronic obstructive pulmonary disease (COPD), heart disease, and diabetes. The CDC also recommends annual immunization for caregivers and household contacts of these high-risk groups; such as relatives and health-care providers.
    About Fluzone Vaccine
    Fluzone vaccine is given to persons 6 months of age and older for active immunization against influenza virus types A and B contained in the vaccine. A Fluzone vaccine formulation (trade name: Fluzone(R), Influenza Virus Vaccine, No Preservative) that does not contain a preservative at any stage in the manufacturing process was introduced in 2004-2005. It is the first FDA- licensed injectable influenza vaccine to be manufactured in this way.
    Safety Information
    Side effects to Fluzone vaccine are soreness at the injection site that can last up to 2 days, pain, and swelling; fever, fatigue, and muscular pain. Other side effects may occur. Fluzone vaccine should not be administered to anyone with a history of serious allergic reaction to any vaccine component, including eggs, egg products, or thimerosal (the only Fluzone vaccine product containing thimerosal is the multi-dose vial), or to persons who have been previously diagnosed with Guillain-Barre syndrome (GBS). If you notice any other problems or symptoms following vaccination, please contact your health- care professional immediately. Vaccination with Fluzone vaccine may not protect all individuals.
    For more information about Fluzone vaccine, talk to your health-care professional. The full prescribing information for Fluzone vaccine can be obtained at http://www.fluzone.com/
    About sanofi-aventis
    Sanofi-aventis, a leading global pharmaceutical company, discovers, develops and distributes therapeutic solutions to improve the lives of everyone. Sanofi-aventis is listed in Paris (EURONEXT: SAN) and in New York .
    Sanofi Pasteur, the vaccines division of sanofi-aventis Group, provided more than a 1.6 billion doses of vaccine in 2007, making it possible to immunize more than 500 million people across the globe. A world leader in the vaccine industry, sanofi pasteur offers the broadest range of vaccines protecting against 20 infectious diseases. The company's heritage, to create vaccines that protect life, dates back more than a century. Sanofi Pasteur is the largest company entirely dedicated to vaccines. Every day, the company invests more than EUR 1 million in research and development. For more information, please visit: http://www.sanofipasteur.com/ or http://www.sanofipasteur.us/
    Forward Looking Statements
    This press release contains forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995, as amended. Forward-looking statements are statements that are not historical facts. These statements include financial projections and estimates and their underlying assumptions, statements regarding plans, objectives, intentions and expectations with respect to future events, operations, products and services, and statements regarding future performance. Forward-looking statements are generally identified by the words "expects,""anticipates,""believes,""intends,""esti mates,""plans" and similar expressions. Although sanofi-aventis' management believes that the expectations reflected in such forward-looking statements are reasonable, investors are cautioned that forward-looking information and statements are subject to various risks and uncertainties, many of which are difficult to predict and generally beyond the control of sanofi-aventis, that could cause actual results and developments to differ materially from those expressed in, or implied or projected by, the forward- looking information and statements. These risks and uncertainties include those discussed or identified in the public filings with the SEC and the AMF made by sanofi-aventis, including those listed under "Risk Factors" and "Cautionary Statement Regarding Forward-Looking Statements" in sanofi-aventis' annual report on Form 20-F for the year ended December 31, 2007. Other than as required by applicable law, sanofi-aventis does not undertake any obligation to update or revise any forward-looking information or statements.
    US Media Relations Len Lavenda T. +1-570-839-4446 len.lavenda@sanofipasteur.com Donna Cary T. +1-570-839-4732 donna.cary@sanofipasteur.com
    Sanofi Pasteur
    CONTACT: US Media Relations, Len Lavenda, +1-570-839-4446,len.lavenda@sanofipasteur.com; Donna Cary, +1-570-839-4732,donna.cary@sanofipasteur.com
    Web site: http://www.fluzone.com/http://www.sa...fipasteur.com/



    Source: PRNewswire

  • #2
    Re: Sanofi Pasteur Shipping First Doses of Influenza Vaccine for the 2008-2009 Season in the US

    "..This year's influenza vaccine contains three new strains of the influenza virus, A/Brisbane/59/2007 (H1N1)-like virus; A/Brisbane/10/2007 (H3N2)-like virus; B/Florida/4/2006-like virus. The three strains for the new influenza vaccine formulation were confirmed by the FDA's Vaccines and Related Biological Products Advisory Committee in February 2008 and correspond with recommendations made by the World Health Organization in February. Unlike other routinely recommended vaccines whose formulation remains constant over time, influenza vaccine is formulated each year to match the strains predicted to circulate during the upcoming season.
    "Introduction of three new strains for the influenza vaccine was unprecedented.......

    The CDC recommends an annual influenza immunization for anyone who wishes to reduce their risk of contracting influenza; children 6 months through 18 years of age; adults over 50 years of age; pregnant women; and anyone with chronic health conditions, such as asthma, chronic obstructive pulmonary disease (COPD), heart disease, and diabetes. The CDC also recommends annual immunization for caregivers and household contacts of these high-risk groups; such as relatives and health-care providers....."

    Comment


    • #3
      Re: Seasonal Flu 2008 - 2009

      #1:
      "Influenza Immunization Recommendations
      The CDC recommends that health-care providers begin offering influenza vaccine as soon as vaccine becomes available, and continue immunization efforts throughout the season. Health-care providers are urged to continue immunization efforts until the end of influenza season. Approximately 250 million people, or 4 out of 5 residents of the U.S., are recommended to receive the influenza vaccine annually."

      Comment


      • #4
        Re: Seasonal Flu 2008 - 2009

        Previous seasonal flu thread:

        Comment


        • #5
          Re: Seasonal Flu 2008 - 2009

          New ECDC Update about seasonal human influenzavirus A/H1N1 resistant to oseltamivir (with tables) at: http://www.flutrackers.com/forum/sho...&postcount=135

          Comment


          • #6
            Re: Seasonal Flu 2008 - 2009

            [EISS, SEASONAL INFLUENZA, EUROPEAN UNION, UPDATES] EISS - Inter-season Electronic Bulletin - Week 31 : 28/07/2008-03/08/2008 - 08 August 2008, Issue N? 269 - SPORADIC INFLUENZA ACTIVITY IN EUROPE
            Summary:
            Influenza virus detections are currently sporadic in Europe. In week 30/2008 there was one detection and in week 31/2008 there were five detections.
            The geographical spread was reported by 13 countries: one country reported sporadic influenza activity as and 12 countries reported no influenza activity.
            In weeks 30-31/2008, six influenza viruses were detected in Europe all in non sentinel samples: in week 30 in England one influenza virus type A, in week 31 in Poland one influenza virus type A, in England three type A viruses and one type B virus.
            Even if the numbers of specimens collected from sentinel and non-sentinel systems is approximate the same, the detections where made in non sentinel specimens and there is an increase in type A virus presence (see graph and table for further details).
            There have been no reports of unusual influenza activity in Europe at a community level (i.e. in a region or local area such as a city, county or district) since week 16/2008.
            Background:
            The Inter-season Electronic Bulletin presents and comments influenza activity based on virological data reported to EISS. In weeks 30/2008 and 31/2008, a total of 15 countries reported virological data to EISS. The Inter-season Electronic Bulletin will be published between week 21/2008 and week 39/2008.
            The spread of influenza virus strains and their epidemiological impact in Europe are being monitored by EISS in collaboration with the WHO Collaborating Centre in London (United Kingdom) and the European Centre for Disease Prevention and Control in Stockholm (Sweden).
            Map
            The map presents the geographical spread as assessed by each of the networks in EISS.

            A = Dominant virus A
            H1N1 = Dominant virus A(H1N1)
            H3N2 = Dominant virus A(H3N2)
            H1N2 = Dominant virus A(H1N2)
            B = Dominant virus B
            A & B = Dominant virus A & B
            = : stable clinical activity
            + : increasing clinical activity
            - : decreasing clinical activity
            No activity = no evidence of influenza virus activity (clinical activity remains at baseline levels)
            Sporadic = isolated cases of laboratory confirmed influenza infection
            Local outbreak = increased influenza activity in local areas (e.g. a city) within a region, or outbreaks in two or more institutions (e.g. schools) within a region. Laboratory confirmed.
            Regional activity = influenza activity above baseline levels in one or more regions with a population comprising less than 50% of the country's total population. Laboratory confirmed.
            Widespread = influenza activity above baseline levels in one or more regions with a population comprising 50% or more of the country's population. Laboratory confirmed.
            Network comments (where available)
            * Norway - No influenza virus detections since one case of influenza B was reported from Northern Norway in week 29. In Northern Norway, low-grade but continuous sporadic circulation had persisted until then.
            * Switzerland - No influenza viruses detcted since the week 17.
            -
            -------

            Comment


            • #7
              Re: Seasonal Flu 2008 - 2009

              H1N2? Never seen that one before. Interesting.....

              Comment


              • #8
                Re: Seasonal Flu 2008 - 2009

                Originally posted by scottmcpherson View Post
                H1N2? Never seen that one before. Interesting.....
                Yes. H1N2 is a reassortant strain (A/H1N1 + A/H3N2) that appeared in some countries some years ago, but since then only sporadically detected. It seems that human antibodies against A/H1 and A/H3 do cross-react with this reassortant strain.

                Comment


                • #9
                  Re: Seasonal Flu 2008 - 2009

                  (1) [ECDC, AVIAN INFLUENZA, POULTRY, NIGERIA, PANDEMIC PREPAREDNESS, UPDATES] EUROPEAN CENTRE OF DISEASES PREVENTION AND CONTROL (ECDC), INFLUENZA NEWS, EXCERPTS

                  (1a) AVIAN INFLUENZA ? ANIMAL HEALTH ? NIGERIA
                  13th August 2008
                  Although there are no new cases of A(H5N1) reported to OIE this week, the OIE have issued a press release following the first confirmed case of High pathogenic A(H5N1) in Nigeria since January 2008.
                  Analysis suggests that one of positive cases, which were identified during routine surveillance in Nigeria, closely resembles the virus isolated from wild birds in Central Europe (Romania and the Czech Republic ) in 2007.
                  It is the first detection of this strain on the Africa continent. It is still unclear how the virus of this specific sublineage was introduced into Africa.
                  The press release concludes that the analysis therefore indicates that the infection in Nigeria was not caused by a new strain of the virus and that there is no evidence of increased human health risks linked to the novel introduction of this strain into Africa.

                  (1b) SCIENTIFIC ADVANCES ? AVIAN INFLUENZA ? EPIDEMIOLOGY
                  14th August 2008

                  Environmental contamination during influenza A virus (H5N1) outbreaks, Cambodia, 2006. - Vong S, Ly S, Mardy S, Holl D, Buchy P. - Emerg Infect Dis. 2008 Aug. Available from:http://www.cdc.gov/EID/content//14/8/1303.htm

                  Description:
                  Cambodia is a country where ?bird flu?, highly pathogenic influenza A(H5N1), is considered firmly entrenched in domestic poultry in backyard flocks.
                  Many of these are small flocks of ducks kept by families as an essential food source. This group working in rural Cambodian areas undertook extensive surveys attempting to detect (by PCR) or isolate (by culture) influenza A(H5N1) viruses in the environment of households within one kilometer of confirmed outbreaks of birds or confirmed human cases.
                  They sampled mud, still water (ponds), soil and water plants. Of 77 samples in and around 14 households areas in three villages between February and August 2006 27 were positive for A(H5N1) by PCR testing. Viral RNA was detectable in poultry faeces, soil, some unconcentrated water, mud, water plants and feathers of dead poultry. However it was not possible to isolate any viruses.

                  ECDC Comment (14/08/08):
                  Environmental specimens are rarely reported on during investigations of outbreaks of highly pathogenic avian influenza involving humans and for this reason alone the role of environmental contamination in infecting humans is unclear.
                  There are anecdotal reports where it is suggested that the environment may be the source of confirmed infections in humans but usually there are alternative routes of exposure and so it has never been possible to demonstrate or exclude transmission of A(H5N1) from the environment to humans.(1)
                  As the authors note though they have detected viral RNA of A(H5N1) the fact that they could not culture the virus could mean that the virus was only present at low dose levels that may not represent a risk to humans.(1)
                  It must always be remembered that A(H5N1) in its current form does not infect humans readily).(2)
                  However because the sampling here was usually after the outbreak it could be argued that there was higher and more dangerous levels of environmental contamination earlier in the outbreaks.
                  Other avian influenza viruses have infected humans through fomites, notably feathers from infected birds causing conjunctivitis.(3,4)
                  But these may have been infections by more infectious avian influenza viruses.
                  The conclusion of this important study is that A(H5N1) can be found in the environment but that it is not yet clear this environmental contamination represents a human health risk. That can only be determined by thorough investigations of ?hot? outbreaks.
                  ECDC has a ?Beta-test? version of a protocol for such investigations which includes environmental sampling.(5) However this publication is a good reminder to those who come into contracts with poultry and their detritus that both represent a potential health risk through avian influenza and other zoonotic infections.(6)

                  1) Vong S, Ly S, Mardy S, Holl D, Buchy P. Environmental contamination during influenza A virus (H5N1) outbreaks, Cambodia, 2006. Emerg Infect Dis. 2008 Aug Available from http://www.cdc.gov/EID/content//14/8/1303.htm
                  2) ECDC Risk Assessment on H5N1 The public health risk from highly pathogenic avian influenza viruses emerging in Europe with specific reference to influenza type A/H5N1.
                  3) Kurtz J, Manvell J, Banks J. Avian influenza virus isolated from a woman with conjunctivitis. Lancet 1996; 348: 901-2.
                  4) Tweed SA, Skowronski DM, David ST, et al Human illness from avian influenza H7N3, British Columbia. Emerg Infect Dis. 2004 Dec;10(12):2196-9.
                  5) ECDC Avian influenza tool-kit Beta Test Version
                  6) ECDC Health advice for people living in or travelling to countries where the A/H5N1 has been detected

                  (1c) P.H. DEVLOPMENTS- SEASONAL INFLUENZA- VACCINES - United States ? update of recommendations for seasonal influenza immunisation by the Advisory Committee on Immunisation Practices 2008
                  ACIP / CDC Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008 MMWR August 8, 2008 / 57(RR07);1-60 http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5707a1.htm

                  The official body advising on immunisation in the United States is the national Advisory Committee on Immunisation Practices (ACIP) which is convened by the US Centers for Disease Prevention and Control (CDC) but has largely external representation and an external chair.
                  It?s recommendations are very influential in the USA, especially for government funded programmes. Most years it updates its guidance on influenza prevention including immunisation and did so this month for the coming 2008-9 season for both adults and children. The recommendations for adults have not changed (Table 1).
                  However a significant change this coming season is that the ACIP is recommending the extension of annual influenza vaccination to all children and adolescents (aged 6 months to 18 years) when previously it was recommending vaccination only for children from 6 months to 4 years.(Table 2)
                  Table 1: Summary of United States influenza vaccination recommendations 2008: Adults (1)
                  Annual vaccination against influenza is recommended for any adult who wants to reduce the risk for becoming ill with influenza or of transmitting to others.
                  Vaccination also is recommended for all adults in the following groups, because these persons are either at high risk for influenza complications, or are close contacts of persons at higher risk:
                  • Persons aged > 50 years
                  • Woman who will be pregnant during the influenza season
                  • Persons who have chronic pulmonary (including asthma) , cardiovascular (except hypertension), renal, hepatic, haematological or metabolic disorders (including diabetes mellitus)
                  • Persons who are immunosuppressed (including immunosuppression caused by medications or by human immunodeficiency virus)
                  • Persons who have any condition (e.g. cognitive dysfunction, spinal cord injuries , seizure disorders, or other neuromuscular disorders) that can compromise respiratory function or the handling of respiratory secretions or that can increase the risk for aspiration
                  • Residents of nursing homes and other chronic-care facilities
                  • Health-care personnel
                  • Household contacts and caregivers of children aged <5 years and adults aged > 50 years, with particular emphasis on vaccinating contacts of children aged < 6 months; and
                  • Household contacts and caregivers of persons with medical conditions that put them at high risk for severe complications from influenza
                  Table 2: Summary of United States Influenza vaccination recommendations, 2008: children and adolescents aged 6 months -18 years (1)
                  Vaccination of all children aged 6 months ? 18 years should begin before or during the 2008-09 influenza season if feasible, but no later than during the 2009-10 influenza season. Vaccination of all children aged 5-18 years is a new recommendation.
                  Children and adolescents at high risk for influenza complications should be a focus of vaccination efforts as providers and programs transition to routinely vaccinating all children and adolescents. Children and adolescents at higher risk for influenza complication are those:
                  • Aged 6 months - 4 years
                  • Who have chronic pulmonary (including asthma), cardiovascular (except hypertension), renal, hepatic, haematological or metabolic disorders (including diabetes mellitus)
                  • Who are immunosuppressed (including immunosuppression caused by medications or by human immunodeficiency virus)
                  • Who have any condition (e.g. cognitive dysfunction, spinal cord injuries , seizure disorders, or other neuromuscular disorders) that can compromise respiratory function or the handling of respiratory secretions or that can increase the risk for aspiration
                  • Who are receiving long-term aspirin therapy who therefore might be at risk for experiencing Reye syndrome after influenza virus infection
                  • Who are residents of chronic-care facilities; and
                  • Who will be pregnant during the influenza season
                  The document goes beyond immunisation giving extensive advice on the use of antivirals (the neuraminidase inhibitors) in treatment and prevention of influenza. The groups for whom these are recommended are in Tables 3 & 4.
                  Table 3: United States Recommendations (2008) on persons for whom antiviral influenza treatment (neuraminidase inhibititors) should be considered (1)
                  If possible, antiviral treatment should be started within 48 hours of influenza illness onset. The effectiveness of initiating antiviral treatment > 48 hours after illness onset has not been established. Persons for whom antiviral treatment should be considered include:
                  • Persons hospitalized with laboratory-confirmed influenza (limited data suggests benefit even for persons whose antiviral treatment is initiated > 48 hours after illness onset)
                  • Persons with laboratory-confirmed influenza pneumonia
                  • Persons with laboratory confirmed influenza and bacterial co infection
                  • Persons with laboratory confirmed influenza infection who are at higher risk for influenza complications ,and
                  • Persons presenting to medical care with laboratory confirmed influenza within 48 hours of influenza illness onset who want to decrease the duration or severity of their symptoms and transmission of influenza to others at higher risk for complications
                  Table 4: United States Recommendations on persons for whom antiviral influenza chemoprophylaxis (neuraminidase inhibitors) should be considered during periods of increased influenza activity in the community (1)
                  • Persons at high risk during the 2 weeks after influenza vaccination ( after the second dose for children aged < 9 years who have not previously been vaccinated ), if influenza viruses are circulating in the community
                  • Persons at high risk for whom influenza vaccine is contraindicated
                  • Family members or health-care providers who are unvaccinated and are likely to have ongoing, close exposure to persons at high risk or unvaccinated persons or infants aged < 6 months
                  • Persons at high risk and their family members and close contacts, and health-care workers, when circulating strains of influenza virus in the community are not matched with vaccine strains
                  • Persons with immune deficiencies or those who might not respond to vaccination (e.g. persons infected with human immunodeficiency virus or with other immunosuppresed conditions, or who are receiving immunosuppressive medications), and
                  • Unvaccinated staff and persons during response to an outbreak in a closed institutional setting with residents at high risk (e.g. extended-care facilities)
                  ECDC Comment (14/08/08):
                  These American guidelines (60 pages long with 500 references) are in themselves a useful document. The recommendations are for a wider use of influenza vaccine than for most other countries. In 2006, CDC estimated that the ACIP U.S. guidelines and recommendations called for 73% of the U.S. population to be immunised.
                  That percentage will now be higher with the addition of the 5 to 17 year age group. ECDC estimates that the equivalent percentages in EU countries (where most recommendations are to focus on the older age and chronic sick risk groups) will be between 18% and 28% of the population depending on the age-structure.
                  However like most European countries the actual coverage in the USA is less than recommended. Coverage surveys undertaken for CDC suggested that for the 2005/6 season an estimated 32% of the US population were actually immunised, though including 64% of the population aged 65 years and above.(2)
                  Antiviral usage is considerably higher in the United States than in European countries where if there is guidance on use it is usually restrictive.(3) ECDC is currently developing guidance on antiviral use and this will be available for consultation shortly.

                  1. ACIP / CDC Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008 MMWR August 8, 2008 / 57(RR07);1-60 http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5707a1.htm
                  2. United States Centers for Disease Control and Prevention. Available from: http://www.cdc.gov/flu/professionals/vaccination/pdf/targetpopchart.pdf
                  3. Stephenson I, Clark TW, Pareek M. Antiviral treatment and prevention of seasonal influenza: A comparative review of recommendations in the European Union. J Clin Virol (2008), doi:10.1016/j.jcv.2008.04.001

                  (1d) P.H. DEVLOPMENTS- SEASONAL INFLUENZA - COMMUNICATION - Innovative Public Advertising for Influenza Vaccination in Children on the Web ? Western Australia

                  In most European Countries it is not policy to recommend immunisation of children against influenza, unless the children have chronic medical conditions that would place them at higher than average risk of severe disease should they become infected with influenza.
                  As readers can see from the last item it is policy to do so in the United States. It is also policy in parts of Australia.
                  The Health Department of the Government of Western Australia has come up with an innovative piece of public advertising that ECDC would like to draw to your attention. See Western Australia Influenza Vaccination Video Clip and enjoy.
                  ECDC welcomes examples of innovative communication from Member states which is will make available through its Influenza Innovations and Good Practice web pages
                  -
                  --------

                  Comment


                  • #10
                    Re: Seasonal Flu 2008 - 2009

                    Originally posted by scottmcpherson View Post
                    H1N2? Never seen that one before. Interesting.....
                    <LI type=square>Influenza A virus (A/Alabama/1/2003(H1N2)) <LI type=square>Influenza A virus (A/Baden-Wuerrtemberg/129/2003(H1N2)) <LI type=square>Influenza A virus (A/Baden-Wuerrtemberg/20/2003(H1N2)) <LI type=square>Influenza A virus (A/Canada/4/2001(H1N2)) <LI type=square>Influenza A virus (A/Denmark/12/03(H1N2)) <LI type=square>Influenza A virus (A/Denmark/12/2003(H1N2)) <LI type=square>Influenza A virus (A/Denmark/50/2003(H1N2)) <LI type=square>Influenza A virus (A/Denmark/86/03(H1N2)) <LI type=square>Influenza A virus (A/duck/NC/91347/01(H1N2)) <LI type=square>Influenza A virus (A/duck/NZL/41/1984(H1N2)) <LI type=square>Influenza A virus (A/Egypt/21181/2001(H1N2)) <LI type=square>Influenza A virus (A/Egypt/84/2001(H1N2)) <LI type=square>Influenza A virus (A/Egypt/96/2002(H1N2)) <LI type=square>Influenza A virus (A/England/1/02(H1N2)) <LI type=square>Influenza A virus (A/England/161/02(H1N1)) <LI type=square>Influenza A virus (A/England/18/02(H1N2)) <LI type=square>Influenza A virus (A/England/2/2002(H1N2)) <LI type=square>Influenza A virus (A/England/3/02(H1N2)) <LI type=square>Influenza A virus (A/England/5/02(H1N2)) <LI type=square>Influenza A virus (A/England/57/02(H1N2)) <LI type=square>Influenza A virus (A/England/627/01(H1N2)) <LI type=square>Influenza A virus (A/England/689/01(H1N2)) <LI type=square>Influenza A virus (A/England/691/01(H1N2)) <LI type=square>Influenza A virus (A/England/73/02(H1N2)) <LI type=square>Influenza A virus (A/England/90/02(H1N2)) <LI type=square>Influenza A virus (A/England/97/02(H1N2)) <LI type=square>Influenza A virus (A/Georgia/2/2003(H1N2)) <LI type=square>Influenza A virus (A/GF/NJ/8848-17/1998(H11N2)) <LI type=square>Influenza A virus (A/Harbin/1/1988(H1N2)) <LI type=square>Influenza A virus (A/Harbin/1/1989(H1N2)) <LI type=square>Influenza A virus (A/Hawaii/10/2002(H1N2)) <LI type=square>Influenza A virus (A/Hebei/24/1989(H1N2)) <LI type=square>Influenza A virus (A/India/66139/2001(H1N2)) <LI type=square>Influenza A virus (A/India/66193/2001(H1N2)) <LI type=square>Influenza A virus (A/India/77251/2001(H1N2)) <LI type=square>Influenza A virus (A/India/77267/2001(H1N2)) <LI type=square>Influenza A virus (A/India/77302/2001(H1N2)) <LI type=square>Influenza A virus (A/India/77308/2001(H1N2)) <LI type=square>Influenza A virus (A/Israel/6/2002(H1N2)) <LI type=square>Influenza A virus (A/Israel/7/2002(H1N2)) <LI type=square>Influenza A virus (A/Latvia/686/2002(H1N2)) <LI type=square>Influenza A virus (A/mallard duck/New York/170/1982(H1N2)) <LI type=square>Influenza A virus (A/Memphis/6/2003(H1N2)) <LI type=square>Influenza A virus (A/Michigan/2/2003(H1N2)) <LI type=square>Influenza A virus (A/Michigan/3/2003(H1N2)) <LI type=square>Influenza A virus (A/murre/Alaska/175/1976(H1N2)) <LI type=square>Influenza A virus (A/Nevada/5/2001(H1N2)) <LI type=square>Influenza A virus (A/New York/2/2003(H1N2)) <LI type=square>Influenza A virus (A/New York/209/2003(H1N2)) <LI type=square>Influenza A virus (A/New York/211/2003(H1N2)) <LI type=square>Influenza A virus (A/New York/217/2002(H1N2)) <LI type=square>Influenza A virus (A/New York/219/2003(H1N2)) <LI type=square>Influenza A virus (A/New York/225/2003(H1N2)) <LI type=square>Influenza A virus (A/New York/226/2003(H1N2)) <LI type=square>Influenza A virus (A/New York/229/2003(H1N2)) <LI type=square>Influenza A virus (A/New York/231/2003(H1N2)) <LI type=square>Influenza A virus (A/New York/26/2002(H1N2)) <LI type=square>Influenza A virus (A/New York/294/2003(H1N2)) <LI type=square>Influenza A virus (A/New York/295/2003(H1N2)) <LI type=square>Influenza A virus (A/New York/296/2003(H1N2)) <LI type=square>Influenza A virus (A/New York/297/2003(H1N2)) <LI type=square>Influenza A virus (A/New York/298/2003(H1N2)) <LI type=square>Influenza A virus (A/New York/299/2003(H1N2)) <LI type=square>Influenza A virus (A/New York/3/2003(H1N2)) <LI type=square>Influenza A virus (A/New York/300/2003(H1N2)) <LI type=square>Influenza A virus (A/New York/349/2003(H1N2)) <LI type=square>Influenza A virus (A/New York/400/2003(H1N2)) <LI type=square>Influenza A virus (A/New York/417/2002(H1N2)) <LI type=square>Influenza A virus (A/New York/481/2003(H1N2)) <LI type=square>Influenza A virus (A/New York/482/2003(H1N2)) <LI type=square>Influenza A virus (A/New York/487/2003(H1N2)) <LI type=square>Influenza A virus (A/New York/489/2003(H1N2)) <LI type=square>Influenza A virus (A/New York/490/2003(H1N2)) <LI type=square>Influenza A virus (A/New York/491/2003(H1N2)) <LI type=square>Influenza A virus (A/New York/492/2003(H1N2)) <LI type=square>Influenza A virus (A/New York/78/2002(H1N2)) <LI type=square>Influenza A virus (A/New York/C1/2003(H1N2)) <LI type=square>Influenza A virus (A/North Carolina/7/2002(H1N2)) <LI type=square>Influenza A virus (A/NWS-Mvi(H1N2)) <LI type=square>Influenza A virus (A/NWS-Tokyo(H1N2)) <LI type=square>Influenza A virus (A/Oman/16353/2001(H1N2)) <LI type=square>Influenza A virus (A/Pennsylvania/1/2001(H1N2)) <LI type=square>Influenza A virus (A/Pennsylvania/1/2002(H1N2)) <LI type=square>Influenza A virus (A/Pennsylvania/1/2003(H1N2)) <LI type=square>Influenza A virus (A/Philippines/344/2004(H1N2)) <LI type=square>Influenza A virus (A/reassortant variant Stubby X-7(F1)Clx2(H1N2)) <LI type=square>Influenza A virus (A/reassortant variant X-7 (H1N2)) <LI type=square>Influenza A virus (A/reassortant variant X-7(F1)(H1N2)) <LI type=square>Influenza A virus (A/Rheinland-Pfalz/34/2003(H1N2)) <LI type=square>Influenza A virus (A/RI/5+/1957(H1N2)) <LI type=square>Influenza A virus (A/Sachsen/05.03.02/2002(H1N2)) <LI type=square>Influenza A virus (A/Sachsen/11.03.02/2002(H1N2)) <LI type=square>Influenza A virus (A/Sachsen/678/2003(H1N2)) <LI type=square>Influenza A virus (A/Saudi Arabia/2231/2001(H1N2)) <LI type=square>Influenza A virus (A/Saudi Arabia/2581/2001(H1N2)) <LI type=square>Influenza A virus (A/Scotland/122/01(H1N2)) <LI type=square>Influenza A virus (A/Scotland/15/02(H1N2)) <LI type=square>Influenza A virus (A/shorebird/Korea/S6/2006(H1N2)) <LI type=square>Influenza A virus (A/Singapore/63/2001(H1N2)) <LI type=square>Influenza A virus (A/Singapore/66/2001(H1N2)) <LI type=square>Influenza A virus (A/Singapore/73/2001(H1N2)) <LI type=square>Influenza A virus (A/Stockholm/13/2002(H1N2)) <LI type=square>Influenza A virus (A/SW/AR/12491/00(H1N2)) <LI type=square>Influenza A virus (A/SW/CO/17871/01(H1N2)) <LI type=square>Influenza A virus (A/sw/Ehime/1/1980(H1N2)) <LI type=square>Influenza A virus (A/sw/Gent/108/01(H1N2)) <LI type=square>Influenza A virus (A/sw/Gent/24/00(H1N2)) <LI type=square>Influenza A virus (A/sw/Gent/7625/99(H1N2)) <LI type=square>Influenza A virus (A/SW/IN/14810-S/01(H1N2)) <LI type=square>Influenza A virus (A/SW/IN/14810-T/01(H1N2)) <LI type=square>Influenza A virus (A/sw/Kanagawa/2/1978(H1N2)) <LI type=square>Influenza A virus (A/SW/KS/13481-S/00(H1N2)) <LI type=square>Influenza A virus (A/SW/KS/13481-T/00(H1N2)) <LI type=square>Influenza A virus (A/SW/MN/12883/00(H1N2)) <LI type=square>Influenza A virus (A/SW/MN/13124-S/01(H1N2)) <LI type=square>Influenza A virus (A/SW/MN/13130/00(H1N2)) <LI type=square>Influenza A virus (A/SW/MN/16356/01(H1N2)) <LI type=square>Influenza A virus (A/SW/MN/16419/01(H1N2)) <LI type=square>Influenza A virus (A/SW/MN/1662/99(H1N2)) <LI type=square>Influenza A virus (A/SW/MN/17138/01(H1N2)) <LI type=square>Influenza A virus (A/SW/MN/22860-S/01(H1N2)) <LI type=square>Influenza A virus (A/SW/MN/22860-T/01(H1N2)) <LI type=square>Influenza A virus (A/SW/MN/23124-S/01(H1N2)) <LI type=square>Influenza A virus (A/SW/MN/23124-T/01(H1N2)) <LI type=square>Influenza A virus (A/SW/MN/3128/00(H1N2)) <LI type=square>Influenza A virus (A/SW/MN/3227/00(H1N2)) <LI type=square>Influenza A virus (A/SW/MN/3327/00(H1N2)) <LI type=square>Influenza A virus (A/SW/MN/34893/01(H1N2)) <LI type=square>Influenza A virus (A/SW/MO/1877/01(H1N2)) <LI type=square>Influenza A virus (A/SW/MO/18777/01(H1N2)) <LI type=square>Influenza A virus (A/SW/NC/17366/01(H1N2)) <LI type=square>Influenza A virus (A/SW/NC/45319/99(H1N2)) <LI type=square>Influenza A virus (A/SW/NE/18339/01(H1N2)) <LI type=square>Influenza A virus (A/SW/NE/21147/01(H1N2)) <LI type=square>Influenza A virus (A/SW/OH/7802/00(H1N2)) <LI type=square>Influenza A virus (A/swine/Bakum/1832/2000(H1N2)) <LI type=square>Influenza A virus (A/swine/Bakum/1833/00(H1N2)) <LI type=square>Influenza A virus (A/swine/Cloppenburg/IDT4777/2005(H1N2)) <LI type=square>Influenza A virus (A/swine/Cotes d'Armor/1122/00(H1N2)) <LI type=square>Influenza A virus (A/swine/Cotes d'Armor/2433/98(H1N2)) <LI type=square>Influenza A virus (A/swine/Cotes d'Armor/604/99(H1N2)) <LI type=square>Influenza A virus (A/swine/Cotes d'Armor/790/97(H1N2)) <LI type=square>Influenza A virus (A/swine/Cotes d'Armor/799/00 (H1N2)) <LI type=square>Influenza A virus (A/swine/Cotes d'Armor/800/00(H1N2)) <LI type=square>Influenza A virus (A/swine/Doetlingen/IDT4735/2005(H1N2)) <LI type=square>Influenza A virus (A/swine/England/17394/96(H1N2)) <LI type=square>Influenza A virus (A/swine/England/438207/94(H1N2)) <LI type=square>Influenza A virus (A/swine/England/690421/95(H1N2)) <LI type=square>Influenza A virus (A/swine/England/72685/96(H1N2)) <LI type=square>Influenza A virus (A/swine/Guangxi/13/2006(H1N2)) <LI type=square>Influenza A virus (A/swine/Guangxi/17/2005(H1N2)) <LI type=square>Influenza A virus (A/swine/Hainan/1/2005(H1N2)) <LI type=square>Influenza A virus (A/swine/IDT/Bakum1832/2000(H1N2)) <LI type=square>Influenza A virus (A/Swine/Illinois/100084/01 (H1N2)) <LI type=square>Influenza A virus (A/Swine/Illinois/100085A/01 (H1N2)) <LI type=square>Influenza A virus (A/Swine/Indiana/9K035/99 (H1N2)) <LI type=square>Influenza A virus (A/Swine/Indiana/P12439/00 (H1N2)) <LI type=square>Influenza A virus (A/Swine/Iowa/930/01(H1N2)) <LI type=square>Influenza A virus (A/swine/Italy/1081/00(H1N2)) <LI type=square>Influenza A virus (A/swine/Italy/1521/98(H1N2)) <LI type=square>Influenza A virus (A/swine/Italy/1654-1/99(H1N2)) <LI type=square>Influenza A virus (A/swine/Italy/2064/99(H1N2)) <LI type=square>Influenza A virus (A/swine/Kanagawa/2/78(H1N2)) <LI type=square>Influenza A virus (A/swine/Kansas/00246/2004(H1N2)) <LI type=square>Influenza A virus (A/Swine/Korea/CY02/02(H1N2)) <LI type=square>Influenza A virus (A/swine/Korea/GC0502/2005(H1N2)) <LI type=square>Influenza A virus (A/swine/Korea/S11/2005(H1N2)) <LI type=square>Influenza A virus (A/swine/Korea/S14/2006(H1N2)) <LI type=square>Influenza A virus (A/swine/Korea/S15/2006(H1N2)) <LI type=square>Influenza A virus (A/swine/Korea/S5/2005(H1N2)) <LI type=square>Influenza A virus (A/swine/Minnesota/00194/2003(H1N2)) <LI type=square>Influenza A virus (A/swine/Minnesota/1192/2001(H1N2)) <LI type=square>Influenza A virus (A/Swine/Minnesota/1713/00/(H1N2)) <LI type=square>Influenza A virus (A/Swine/Minnesota/55551/00 (H1N2)) <LI type=square>Influenza A virus (A/swine/Miyagi/5/03(H1N2)) <LI type=square>Influenza A virus (A/swine/Miyagi/5/2003(H1N2)) <LI type=square>Influenza A virus (A/swine/Miyazaki/1/2006(H1N2)) <LI type=square>Influenza A virus (A/swine/Nagasaki/1/1989(H1N2)) <LI type=square>Influenza A virus (A/swine/Nagasaki/1/1990(H1N2)) <LI type=square>Influenza A virus (A/Swine/North Carolina/93523/01 (H1N2)) <LI type=square>Influenza A virus (A/Swine/North Carolina/98225/01(H1N2)) <LI type=square>Influenza A virus (A/Swine/Ohio/891/01(H1N2)) <LI type=square>Influenza A virus (A/swine/Ontario/48235/04(H1N2)) <LI type=square>Influenza A virus (A/swine/Ontario/52156/03(H1N2)) <LI type=square>Influenza A virus (A/swine/Ontario/55383/04(H1N2)) <LI type=square>Influenza A virus (A/swine/Pingtung/7-12/1999(H1N2)) <LI type=square>Influenza A virus (A/swine/Pingtung/92-2/2003(H1N2)) <LI type=square>Influenza A virus (A/swine/Saraburi/NIAH13021/2005(H1N2)) <LI type=square>Influenza A virus (A/swine/Scotland/410440/94(H1N2)) <LI type=square>Influenza A virus (A/swine/Taiwan/CO935/2004(H1N2)) <LI type=square>Influenza A virus (A/swine/Zhejiang/1/2004(H1N2)) <LI type=square>Influenza A virus (A/Switzerland/3100/2002(H1N2)) <LI type=square>Influenza A virus (A/Texas/7/2001(H1N2)) <LI type=square>Influenza A virus (A/Turkey/MO/24093/99(H1N2)) <LI type=square>Influenza A virus (A/Virginia/20/2003(H1N2)) <LI type=square>Influenza A virus (A/Wisconsin/12/2001(H1N2)) <LI type=square>Influenza A virus (A/Wisconsin/9/2002(H1N2)) <LI type=square>Influenza A virus (A/Xianfeng/3/1989(H1N2)) <LI type=square>Influenza A virus (A/Yokohama/22/2002(H1N2)) <LI type=square>Influenza A virus (A/Yokohama/47/2002(H1N2))

                    Comment


                    • #11
                      Re: Seasonal Flu 2008 - 2009

                      New Zealand

                      Health warnings of influenza-like virus
                      NEW 10:48AM Friday August 15, 2008

                      A public health warning has been issued as an influenza-like illness does the rounds.

                      The Auckland Regional Public Health Service has been advised by schools of student absences due to coughs, vomiting and high temperatures.

                      Other problems include rapid breathing and chest pain.

                      Medical Officer of Health Craig Thornley says people need to stay home if they are sick to stop the risk of spreading the virus. He says people should wash their hands regularly and cough into their arm, rather than their hand.

                      Dr Thornley says this year's flu immunisation covers all the current virus strains in New Zealand, so people who have been vaccinated are likely to have protection. He says a flu vaccination at the start of winter is still the best protection available.


                      Latest breaking news articles, photos, video, blogs, reviews, analysis, opinion and reader comment from New Zealand and around the World - NZ Herald

                      Comment


                      • #12
                        Re: Seasonal Flu 2008 - 2009

                        Source: http://allafrica.com/stories/200808150352.html

                        Zimbabwe: Wave of Influenza Hits Country

                        The Herald (Harare)
                        Published by the government of Zimbabwe
                        15 August 2008
                        Posted to the web 15 August 2008

                        Harare

                        A WAVE of severe influenza, which has in some cases developed into complications such as pneumonia and diarrhoea, has hit some parts of the country as the cold weather persists.

                        Health and Child Welfare Deputy Minister Dr Edwin Muguti said people who develop that strain of flu should see a doctor early.
                        He, however, said infections caused by viruses were common during winter as people usually remain indoors and get crowded.

                        "We expect the outbreak to go away soon and also encourage people to take a lot of liquids and citrus fruits which contain vitamin C to mitigates the flu," Dr Muguti said.

                        He said affected people should also take anti-biopirates such as paracetamol to deal with chest infections.

                        Symptoms of the flu include splitting headaches, dry coughs and weak joints similar to malaria.

                        "I was attacked by this kind of flu three days ago and had sleepless nights. For some time I thought it was malaria, but a nurse at our local clinic said it was just a severe strain of flu," said Power Kanonhuwa of Kuwadzana. Ms Tsitsi Marunda of Glen View said she was recovering from the flu, which had developed into diarrhoea.

                        Last year, the country was also hit by a wave of influenza, which prompted doctors to warn the public to seek treatment as they said it could develop into more serious complications such as bronchitis, pneumonia and tonsillitis.

                        Comment


                        • #13
                          Re: Seasonal Flu 2008 - 2009

                          [This piece of news is mostly confused. A probable epidemic of seasonal human influenza is spreading in Zamboanga, Philippines but the reporter cites a ''vectorial viral strain'' (that doesn't correspond to influenzaviruses transmission pattern) and further ''bird flu''. I hope more helpful follow-up will be available in the next few days. IOH]
                          -
                          -----
                          1,500 Zambo residents have traces of Malaysian flu
                          By JEWEL REYES

                          ABS-CBN Zamboanga

                          Local health workers in Zamboanga City said Saturday at least 1,500 residents have been found with traces of the "Malaysian flu."

                          Rodel Agbulos, Zamboanga City health officer, said the Malaysian flu or the Malaysian strain virus could have been brought to southern Mindanao by the Filipino illegal immigrants who were recently deported back to the country.

                          Agbulos said the Malaysian flu became prevalent in several Zamboanga City residents after the massive deportation of the illegal immigrants from Malaysia.

                          Agbulos added that the flu could have been reached the city because of its proximity to Malaysia.

                          The health officer said "vectoral viral strain" was detected in tests conducted on the 1,500 pneumonia patients in the city.

                          He said the city health office has alerted the regional office about the presence of the Malaysian flu.

                          Agbulos, meanwhile, calmed residents who have become worried of the Malaysian flu.

                          He said the strain virus is "only a common case of pneumonia."

                          Malaysia has been struck by the dreaded "avian flu" famously called the Bird flu. Its government ordered the killing thousands of birds and chicken were killed to prevent the deadly influenza virus from spreading.
                          -

                          -------

                          Comment


                          • #14
                            Re: Seasonal Flu 2008 - 2009

                            Source: http://www.abs-cbnnews.com/storypage...StoryId=128446

                            Phillipines: 1,500 Zambo residents have traces of Malaysian flu

                            By JEWEL REYES
                            ABS-CBN Zamboanga

                            Local health workers in Zamboanga City said Saturday at least 1,500 residents have been found with traces of the "Malaysian flu."

                            Rodel Agbulos, Zamboanga City health officer, said the Malaysian flu or the Malaysian strain virus could have been brought to southern Mindanao by the Filipino illegal immigrants who were recently deported back to the country.

                            Agbulos said the Malaysian flu became prevalent in several Zamboanga City residents after the massive deportation of the illegal immigrants from Malaysia.

                            Agbulos added that the flu could have been reached the city because of its proximity to Malaysia.


                            The health officer said "vectoral viral strain" was detected in tests conducted on the 1,500 pneumonia patients in the city. He said the city health office has alerted the regional office about the presence of the Malaysian flu.

                            Agbulos, meanwhile, calmed residents who have become worried of the Malaysian flu. He said the strain virus is "only a common case of pneumonia."

                            Malaysia has been struck by the dreaded "avian flu" famously called the Bird flu. Its government ordered the killing thousands of birds and chicken were killed to prevent the deadly influenza virus from spreading.

                            Comment


                            • #15
                              Re: Seasonal Flu 2008 - 2009

                              Originally posted by Shiloh View Post
                              Source: http://allafrica.com/stories/200808150352.html

                              Zimbabwe: Wave of Influenza Hits Country

                              The Herald (Harare)
                              Published by the government of Zimbabwe
                              15 August 2008
                              Posted to the web 15 August 2008

                              Harare

                              A WAVE of severe influenza, which has in some cases developed into complications such as pneumonia and diarrhoea, has hit some parts of the country as the cold weather persists.

                              Health and Child Welfare Deputy Minister Dr Edwin Muguti said people who develop that strain of flu should see a doctor early. He, however, said infections caused by viruses were common during winter as people usually remain indoors and get crowded.

                              "We expect the outbreak to go away soon and also encourage people to take a lot of liquids and citrus fruits which contain vitamin C to mitigates the flu," Dr Muguti said.

                              He said affected people should also take anti-biopirates such as paracetamol to deal with chest infections.

                              Symptoms of the flu include splitting headaches, dry coughs and weak joints similar to malaria.

                              "I was attacked by this kind of flu three days ago and had sleepless nights. For some time I thought it was malaria, but a nurse at our local clinic said it was just a severe strain of flu," said Power Kanonhuwa of Kuwadzana. Ms Tsitsi Marunda of Glen View said she was recovering from the flu, which had developed into diarrhoea.

                              Last year, the country was also hit by a wave of influenza, which prompted doctors to warn the public to seek treatment as they said it could develop into more serious complications such as bronchitis, pneumonia and tonsillitis.
                              <TABLE cellSpacing=0 cellPadding=0 width="100%" border=0><TBODY><TR><TD class=content><TABLE cellSpacing=0 cellPadding=0 width="100%" border=0><TBODY><TR><TD class=content vAlign=top>1.</TD><TD class=content vAlign=top width=161>South Africa</TD><TD class=content vAlign=top>A (H3)</TD><TD class=content vAlign=top align=middle>15</TD><TD class=content vAlign=top align=middle>2008</TD><TD class=content vAlign=top align=middle>0</TD><TD class=content vAlign=top align=middle>view</TD></TR><TR><TD class=content vAlign=top>2.</TD><TD class=content vAlign=top width=161>South Africa</TD><TD class=content vAlign=top>A (H3)</TD><TD class=content vAlign=top align=middle>16</TD><TD class=content vAlign=top align=middle>2008</TD><TD class=content vAlign=top align=middle>0</TD><TD class=content vAlign=top align=middle>view</TD></TR><TR><TD class=content vAlign=top>3.</TD><TD class=content vAlign=top width=161>South Africa</TD><TD class=content vAlign=top>A (H3)</TD><TD class=content vAlign=top align=middle>17</TD><TD class=content vAlign=top align=middle>2008</TD><TD class=content vAlign=top align=middle>1</TD><TD class=content vAlign=top align=middle>view</TD></TR><TR><TD class=content vAlign=top>4.</TD><TD class=content vAlign=top width=161>South Africa</TD><TD class=content vAlign=top>A (H3)</TD><TD class=content vAlign=top align=middle>18</TD><TD class=content vAlign=top align=middle>2008</TD><TD class=content vAlign=top align=middle>1</TD><TD class=content vAlign=top align=middle>view</TD></TR><TR><TD class=content vAlign=top>5.</TD><TD class=content vAlign=top width=161>South Africa</TD><TD class=content vAlign=top>A (H3)</TD><TD class=content vAlign=top align=middle>19</TD><TD class=content vAlign=top align=middle>2008</TD><TD class=content vAlign=top align=middle>0</TD><TD class=content vAlign=top align=middle>view</TD></TR><TR><TD class=content vAlign=top>6.</TD><TD class=content vAlign=top width=161>South Africa</TD><TD class=content vAlign=top>A (H3)</TD><TD class=content vAlign=top align=middle>20</TD><TD class=content vAlign=top align=middle>2008</TD><TD class=content vAlign=top align=middle>0</TD><TD class=content vAlign=top align=middle>view</TD></TR><TR><TD class=content vAlign=top>7.</TD><TD class=content vAlign=top width=161>South Africa</TD><TD class=content vAlign=top>A (H3)</TD><TD class=content vAlign=top align=middle>21</TD><TD class=content vAlign=top align=middle>2008</TD><TD class=content vAlign=top align=middle>0</TD><TD class=content vAlign=top align=middle>view</TD></TR><TR><TD class=content vAlign=top>8.</TD><TD class=content vAlign=top width=161>South Africa</TD><TD class=content vAlign=top>A (H3)</TD><TD class=content vAlign=top align=middle>22</TD><TD class=content vAlign=top align=middle>2008</TD><TD class=content vAlign=top align=middle>0</TD><TD class=content vAlign=top align=middle>view</TD></TR><TR><TD class=content vAlign=top>9.</TD><TD class=content vAlign=top width=161>South Africa</TD><TD class=content vAlign=top>A (H3)</TD><TD class=content vAlign=top align=middle>23</TD><TD class=content vAlign=top align=middle>2008</TD><TD class=content vAlign=top align=middle>1</TD><TD class=content vAlign=top align=middle>view</TD></TR><TR><TD class=content vAlign=top>10.</TD><TD class=content vAlign=top width=161>South Africa</TD><TD class=content vAlign=top>A (H3)</TD><TD class=content vAlign=top align=middle>24</TD><TD class=content vAlign=top align=middle>2008</TD><TD class=content vAlign=top align=middle>0</TD><TD class=content vAlign=top align=middle>view</TD></TR><TR><TD class=content vAlign=top>11.</TD><TD class=content vAlign=top width=161>South Africa</TD><TD class=content vAlign=top>A (H3)</TD><TD class=content vAlign=top align=middle>25</TD><TD class=content vAlign=top align=middle>2008</TD><TD class=content vAlign=top align=middle>1</TD><TD class=content vAlign=top align=middle>view</TD></TR><TR><TD class=content vAlign=top>12.</TD><TD class=content vAlign=top width=161>South Africa</TD><TD class=content vAlign=top>A (H3)</TD><TD class=content vAlign=top align=middle>26</TD><TD class=content vAlign=top align=middle>2008</TD><TD class=content vAlign=top align=middle>0</TD><TD class=content vAlign=top align=middle>view</TD></TR><TR><TD class=content vAlign=top>13.</TD><TD class=content vAlign=top width=161>South Africa</TD><TD class=content vAlign=top>A (H3)</TD><TD class=content vAlign=top align=middle>27</TD><TD class=content vAlign=top align=middle>2008</TD><TD class=content vAlign=top align=middle>1</TD><TD class=content vAlign=top align=middle>view</TD></TR><TR><TD class=content vAlign=top>14.</TD><TD class=content vAlign=top width=161>South Africa</TD><TD class=content vAlign=top>A (H3)</TD><TD class=content vAlign=top align=middle>28</TD><TD class=content vAlign=top align=middle>2008</TD><TD class=content vAlign=top align=middle>0</TD><TD class=content vAlign=top align=middle>view</TD></TR></TBODY></TABLE><!-- END OF CONTENT --></TD><TD class=ContentTop width=14></TD></TR></TBODY></TABLE>

                              Comment

                              Working...
                              X